220 related articles for article (PubMed ID: 23593540)
1. Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules.
Pradip D; Bouzyk M; Dey N; Leyland-Jones B
Am J Cancer Res; 2013; 3(2):173-95. PubMed ID: 23593540
[TBL] [Abstract][Full Text] [Related]
2. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine phosphorylation of growth factor receptor-bound protein-7 by focal adhesion kinase in the regulation of cell migration, proliferation, and tumorigenesis.
Chu PY; Huang LY; Hsu CH; Liang CC; Guan JL; Hung TH; Shen TL
J Biol Chem; 2009 Jul; 284(30):20215-26. PubMed ID: 19473962
[TBL] [Abstract][Full Text] [Related]
4. EGF-induced Grb7 recruits and promotes Ras activity essential for the tumorigenicity of Sk-Br3 breast cancer cells.
Chu PY; Li TK; Ding ST; Lai IR; Shen TL
J Biol Chem; 2010 Sep; 285(38):29279-85. PubMed ID: 20622016
[TBL] [Abstract][Full Text] [Related]
5. Context-dependent role of Grb7 in HER2+ve and triple-negative breast cancer cell lines.
Lim RC; Price JT; Wilce JA
Breast Cancer Res Treat; 2014 Feb; 143(3):593-603. PubMed ID: 24464577
[TBL] [Abstract][Full Text] [Related]
6. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
7. Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression.
Nencioni A; Cea M; Garuti A; Passalacqua M; Raffaghello L; Soncini D; Moran E; Zoppoli G; Pistoia V; Patrone F; Ballestrero A
PLoS One; 2010 Feb; 5(2):e9024. PubMed ID: 20126311
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Cyclic Peptide Inhibitors of the Grb7 Breast Cancer Target: Small Change in Cargo Results in Large Change in Cellular Activity.
Sang J; Kulkarni K; Watson GM; Ma X; Craik DJ; Henriques ST; Poth AG; Benfield AH; Wilce JA
Molecules; 2019 Oct; 24(20):. PubMed ID: 31627265
[TBL] [Abstract][Full Text] [Related]
9. GRB7 dependent proliferation of basal-like, HER-2 positive human breast cancer cell lines is mediated in part by HER-1 signaling.
Luoh SW; Wagoner W; Wang X; Hu Z; Lai X; Chin K; Sears R; Ramsey E
Mol Carcinog; 2019 May; 58(5):699-707. PubMed ID: 30604896
[TBL] [Abstract][Full Text] [Related]
10. β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib.
Huang C; Park CC; Hilsenbeck SG; Ward R; Rimawi MF; Wang YC; Shou J; Bissell MJ; Osborne CK; Schiff R
Breast Cancer Res; 2011 Aug; 13(4):R84. PubMed ID: 21884573
[TBL] [Abstract][Full Text] [Related]
11. GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinoma.
Gotovac JR; Liu DS; Yates MJ; Milne JV; Macpherson AA; Simpson KJ; Eslick GD; Mitchell C; Duong CP; Phillips WA; Clemons NJ
J Pathol; 2020 Nov; 252(3):317-329. PubMed ID: 32737994
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth.
Bourguignon LY; Zhu H; Zhou B; Diedrich F; Singleton PA; Hung MC
J Biol Chem; 2001 Dec; 276(52):48679-92. PubMed ID: 11606575
[TBL] [Abstract][Full Text] [Related]
13. Epigenetically altered miR‑193a‑3p promotes HER2 positive breast cancer aggressiveness by targeting GRB7.
Tang Y; Yang S; Wang M; Liu D; Liu Y; Zhang Y; Zhang Q
Int J Mol Med; 2019 Jun; 43(6):2352-2360. PubMed ID: 31017268
[TBL] [Abstract][Full Text] [Related]
14. Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer.
Nadler Y; González AM; Camp RL; Rimm DL; Kluger HM; Kluger Y
Ann Oncol; 2010 Mar; 21(3):466-473. PubMed ID: 19717535
[TBL] [Abstract][Full Text] [Related]
15. Association of focal adhesion kinase with Grb7 and its role in cell migration.
Han DC; Guan JL
J Biol Chem; 1999 Aug; 274(34):24425-30. PubMed ID: 10446223
[TBL] [Abstract][Full Text] [Related]
16. GRB7 Expression and Correlation With HER2 Amplification in Invasive Breast Carcinoma.
Bivin WW; Yergiyev O; Bunker ML; Silverman JF; Krishnamurti U
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):553-558. PubMed ID: 26945445
[TBL] [Abstract][Full Text] [Related]
17. Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation.
Porter CJ; Matthews JM; Mackay JP; Pursglove SE; Schmidberger JW; Leedman PJ; Pero SC; Krag DN; Wilce MC; Wilce JA
BMC Struct Biol; 2007 Sep; 7():58. PubMed ID: 17894853
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of Rac1 reduces Trastuzumab resistance in PTEN deficient and insulin-like growth factor I receptor overexpressing human breast cancer SKBR3 cells.
Zhao Y; Wang Z; Jiang Y; Yang C
Cancer Lett; 2011 Dec; 313(1):54-63. PubMed ID: 21943825
[TBL] [Abstract][Full Text] [Related]
19. Association of Grb7 with phosphoinositides and its role in the regulation of cell migration.
Shen TL; Han DC; Guan JL
J Biol Chem; 2002 Aug; 277(32):29069-77. PubMed ID: 12021278
[TBL] [Abstract][Full Text] [Related]
20. Association of genetic ancestry with HER2, GRB7 AND estrogen receptor expression among Colombian women with breast cancer.
Rey-Vargas L; Bejarano-Rivera LM; Mejia-Henao JC; Sua LF; Bastidas-Andrade JF; Ossa CA; Gutiérrez-Castañeda LD; Fejerman L; Sanabria-Salas MC; Serrano-Gómez SJ
Front Oncol; 2022; 12():989761. PubMed ID: 36620598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
